Acteurs : Acteur Christine CLAVEL

0
home-8619588
Nom
Pr Christine CLAVEL
Coordonnées
Pr Christine CLAVELCHU ReimsLaboratoire Pol Bouin Hôpital Maison Blanche
51092 REIMS Cedex Tel : +33 3 26 78 82 76Fax : +33 3 26 78 77 39e/m : [email protected]
Affiliation(s)
Equipe de recherche
Equipe CA01 – Christine CLAVEL •
Axes du CGE
2 : Agents infectieux et carcinogenèse
Projets
Equipe CA01

2007 – PGMCCA (porteur : Christine CLAVEL)
DEVELOPPEMENT D’UN PLATEAU TECHNIQUE HOSPITALIER DE GENETIQUE MOLECULAIRE DES CANCERS EN CHAMPAGNE-ARDENNE
2005 – CGE-DKFZ (porteur : Christine CLAVEL)
Deutsches Krebsforschungszentrum (DKFZ)/Cancéropôle du Grand-Est (CGE) joint research programme in Applied Tumour Virology HPV INFECTION AND CANCER
Publications


pixel-1274521
Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ. 2008 Oct 13;337:a1754. doi: 10.1136/bmj.a1754.

Lorenzato M, Caudroy S, Nou JM, Dalstein V, Joseph K, Bellefqih S, Durlach A, Thil C, Dez F, Bouttens D, Clavel C, Birembaut P. Contribution of DNA ploidy image cytometry to the management of ASC cervical lesions. Cancer. 2008 Aug 25;114(4):263-9.

Pretet JL, Jacquard AC, Saunier M, Clavel C, Dachez R, Gondry J, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D. Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study. Gynecol Oncol. 2008 Aug;110(2):179-84. Epub 2008 Jun 2.

Lee K, Magalhaes I, Clavel C, Briolat J, Birembaut P, Tommasino M, Zehbe I. Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression. Virus Res. 2008 Jan;131(1):106-10. Epub 2007 Sep 14.

Briolat J, Dalstein V, Saunier M, Joseph K, Caudroy S, Pretet JL, Birembaut P, Clavel C. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int J Cancer. 2007 Nov 15;121(10):2198-204.

pixel-1274521
Dalstein V, Briolat J, Birembaut P, Clavel C. [The epidemiology of genital human papillomavirus infections] Rev Prat. 2006 Nov 15;56(17):1877-81. Review

pixel-1274521
Conscience I, Jovenin N, Coissard C, Lorenzato M, Durlach A, Grange F, Birembaut P, Clavel C, Bernard P. P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas. Eur J Dermatol. 2006 Sep-Oct;16(5):518-22.

Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine. 2006 Aug 31;24 Suppl 3:S3/78-89. Review

Grodzki M, Besson G, Clavel C, Arslan A, Franceschi S, Birembaut P, Tommasino M, Zehbe I. Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):820-2.

Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006 Sep 1;119(5):1095-101.

Fleury MJ, Touze A, Alvarez E, Carpentier G, Clavel C, Vautherot JF, Coursaget P. Identification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31. Arch Virol. 2006 Aug;151(8):1511-23. Epub 2006 Mar 3.

Lorenzato M, Caudroy S, Bronner C, Evrard G, Simon M, Durlach A, Birembaut P, Clavel C. Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions? Hum Pathol. 2005 Oct;36(10):1101-7.

pixel-1274521
Clavel C, Bory JP, Caudroy S, Lorenzato M, Durlach A, Graesslin O, Quereux C, Birembaut P. Usefulness of HPV testing in the follow-up of untreated cervical low grade lesions. Histol Histopathol. 2005 Oct;20(4):1085-91.

Clavel C, Cucherousset J, Lorenzato M, Caudroy S, Nou JM, Nazeyrollas P, Polette M, Bory JP, Gabriel R, Quereux C, Birembaut P. Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions. Br J Cancer. 2004 May 4;90(9):1803-8.

Polette M, Nawrocki-Raby B, Gilles C, Clavel C, Birembaut P. Tumour invasion and matrix metalloproteinases. Crit Rev Oncol Hematol. 2004 Mar;49(3):179-86. Review
pixel-1274521pixel-1274521pixel-1274521pixel-1274521pixel-1274521home-8619588pixel-1274521uguest-6509325 poweredby-4887325